STRO - SUTRO BIOPHARMA, INC.
IEX Last Trade
1.84
-0.035 -1.902%
Share volume: 7,386
Last Updated: Fri 27 Dec 2024 05:30:26 PM CET
Research and Development in Biotechnology (except Nanobiotechnology):
-0.04%
PREVIOUS CLOSE
CHG
CHG%
$1.88
-0.04
-1.87%
View ratios
| Fiscal Date | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | |
| Report Date | 2022-08-08 | 2022-11-08 | 2023-03-30 | 2023-05-15 | 2023-08-10 | 2023-11-13 | 2024-03-25 | 2024-05-13 | |
| Total revenue | 28.096 M | 25.147 M | 8.632 M | 12.674 M | 10.412 M | 16.924 M | 113.721 M | 13.008 M | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Gross profit | 28.096 M | 25.147 M | 8.632 M | 12.674 M | 10.412 M | 16.924 M | 113.721 M | 13.008 M | |
| -10.50% | -65.67% | 46.83% | -17.85% | 62.54% | 571.95% | -88.56% | |||
| Operating expenses | 47.475 M | 46.357 M | 57.854 M | 54.911 M | 56.591 M | 60.938 M | 70.569 M | 69.599 M | |
| Selling general and admin | 15.143 M | 14.643 M | 14.719 M | 15.512 M | 14.999 M | 15.269 M | 16.804 M | 12.721 M | |
| Research and development | 32.332 M | 31.714 M | 43.135 M | 39.399 M | 41.592 M | 45.669 M | 53.765 M | 56.878 M | |
| Total expenses | 47.475 M | 46.357 M | 57.854 M | 54.911 M | 56.591 M | 60.938 M | 70.569 M | 69.599 M | |
| -2.35% | 24.80% | -5.09% | 3.06% | 7.68% | 15.80% | -1.37% | |||
| Operating income | -19.379 M | -21.210 M | -49.222 M | -42.237 M | -46.179 M | -44.014 M | 43.152 M | -56.591 M | |
| Ebit | -19.379 M | -21.210 M | -49.222 M | -42.237 M | -46.179 M | -44.014 M | 43.152 M | -56.591 M | |
| Pretax income | -23.512 M | -19.488 M | -34.594 M | -49.655 M | -38.373 M | -47.445 M | 46.872 M | -58.213 M | |
| -17.11% | 77.51% | 43.54% | -22.72% | 23.64% | -198.79% | -224.20% | |||
| Income tax | 2.500 M | 0.000 | 0.000 | 395.000 K | 151.000 K | 1.839 M | 15.807 M | 0.000 | |
| Net income basic | -26.012 M | -19.488 M | -34.594 M | -50.050 M | -38.524 M | -49.284 M | 31.065 M | -58.213 M | |
| 25.08% | -77.51% | -44.68% | 23.03% | -27.93% | 163.03% | -287.39% | |||
| Net income | -26.012 M | -19.488 M | -34.594 M | -50.050 M | -38.524 M | -49.284 M | 31.065 M | -58.213 M | |
| 25.08% | -77.51% | -44.68% | 23.03% | -27.93% | 163.03% | -287.39% |